Are colonoscopies to blame for the $2.7 trillion medical bill in the U.S.?

| | Health Imaging | Economics

The price discrepancy between colonoscopies performed in the U.S. and exams in other countries is at the heart of escalating medical costs in the U.S., according to an article in the NY Times. Colonoscopies are over-performed and over-priced in the U.S., the author asserts. Read more at the link below.

The $2.7 Trillion Medical Bill

Related Content

‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
A closer look at how FDA's flurpiridaz approval will impact nuclear cardiology
Cath lab techs and nurses see new normal with post-COVID pay
SpectraWAVE raises $50M for FDA-cleared intravascular imaging technology
CMS could increase CCTA payments—the American College of Cardiology wants to help
Challenges to the financial stability of the American healthcare system

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup